XML 81 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segment, Geographic, and Concentration Risk Information (Tables)
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Summary of Segment Information

Segment information is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Net loss attributable to Athenex, Inc.:

 

 

 

 

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

(108,563

)

 

$

(64,837

)

 

$

(50,257

)

Global Supply Chain Platform

 

 

(7,179

)

 

 

(11

)

 

 

(343

)

Commercial Platform

 

 

(15,428

)

 

 

(22,867

)

 

 

 

Total consolidated net loss attributable to Athenex, Inc.

 

$

(131,170

)

 

$

(87,715

)

 

$

(50,600

)

 

Summary of Revenue by Segments

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Total revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

1,411

 

 

$

998

 

 

$

973

 

Global Supply Chain Platform

 

 

28,427

 

 

 

26,581

 

 

 

17,998

 

Commercial Platform

 

 

17,218

 

 

 

 

 

 

 

Total revenue for reportable segments

 

 

47,056

 

 

 

27,579

 

 

 

18,971

 

Intersegment revenue

 

 

(9,013

)

 

 

(7,028

)

 

 

(5,027

)

Total consolidated revenue

 

$

38,043

 

 

$

20,551

 

 

$

13,944

 

 

Summary of Revenue by Product Group

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Total revenue by product group:

 

 

 

 

 

 

 

 

 

 

 

 

API sales

 

$

15,351

 

 

$

15,331

 

 

$

9,179

 

Medical device sales

 

 

1,747

 

 

 

2,338

 

 

 

1,966

 

Contract manufacturing revenue

 

 

1,360

 

 

 

1,497

 

 

 

1,464

 

Commercial product sales

 

 

17,648

 

 

 

228

 

 

 

224

 

License fees and consulting revenue

 

 

1,105

 

 

 

392

 

 

 

297

 

Grant revenue

 

 

832

 

 

 

765

 

 

 

814

 

Total consolidated revenue

 

$

38,043

 

 

$

20,551

 

 

$

13,944

 

 

Summary of Depreciation, Amortization and Assets by Segment

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Total depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

482

 

 

$

195

 

 

$

101

 

Global Supply Chain Platform

 

 

2,272

 

 

 

1,644

 

 

 

787

 

Commercial Platform

 

 

919

 

 

 

187

 

 

 

 

Total consolidated depreciation and amortization

 

$

3,673

 

 

$

2,026

 

 

$

888

 

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Total assets:

 

 

 

 

 

 

 

 

Oncology Innovation Platform

 

$

65,966

 

 

$

53,022

 

Global Supply Chain Platform

 

 

51,128

 

 

 

48,560

 

Commercial Platform

 

 

23,319

 

 

 

4,308

 

Total assets

 

$

140,413

 

 

$

105,890

 

 

Summary of Revenue by Geographical Segment

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Total revenue

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

19,933

 

 

$

3,573

 

 

$

3,270

 

India

 

 

8,479

 

 

 

7,803

 

 

 

4,914

 

Austria

 

 

3,962

 

 

 

5,197

 

 

 

2,323

 

China

 

 

2,803

 

 

 

2,338

 

 

 

2,366

 

Taiwan

 

 

500

 

 

 

 

 

 

84

 

Other foreign countries

 

 

2,366

 

 

 

1,640

 

 

 

987

 

Total consolidated revenue

 

$

38,043

 

 

$

20,551

 

 

$

13,944

 

 

Summary of Property and Equipment by Geographical Segment

 

 

December 31,

 

 

 

2017

 

 

2016

 

Total property and equipment, net:

 

 

 

 

 

 

 

 

United States

 

$

5,305

 

 

$

2,177

 

China

 

 

4,346

 

 

 

3,633

 

Total property and equipment, net

 

$

9,651

 

 

$

5,810

 

 

Summary of Customer Revenue and Accounts Receivable Concentration

Customer revenue and accounts receivable concentration amounted to the following for the identified periods. These customers relate to the Commercial Platform segment and the Global Supply Chain Platform segment.

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Percentage of total revenue by customer:

 

 

 

 

 

 

 

 

 

 

 

 

Customer A

 

 

19

%

 

 

38

%

 

 

29

%

Customer B

 

 

9

%

 

 

24

%

 

 

17

%

Customer C

 

 

15

%

 

 

 

 

 

 

Customer D

 

 

8

%

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Percentage of total accounts receivable by customer:

 

 

 

 

 

 

 

 

Customer A

 

 

26

%

 

 

50

%

Customer B

 

 

18

%

 

 

9

%

Customer C

 

 

13

%

 

 

 

Customer D

 

 

10

%